Andrx Fortamet Picks Up Exclusivity
This article was originally published in The Pink Sheet Daily
Executive Summary
Andrx' Fortamet (metformin extended-release) has received three years of Waxman/Hatch marketing exclusivity, the company said June 7
You may also be interested in...
Andrx Fortamet Clears FDA; Dosing Convenience Over Glucophage XR Will Be Focus
Patients will be able to achieve optimal daily metformin dose with half as many tablets as Glucophage XR and generics. Andrx is also touting the smaller size of the pills. Fortamet will launch in May.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.